{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T23:10:38Z","timestamp":1723677038970},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12917-015-0343-7","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T08:35:43Z","timestamp":1423730143000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["In vitro dynamic pharmacokinetic\/pharmacodynamic(PK\/PD) modeling and PK\/PD cutoff of cefquinome against Haemophilus parasuis"],"prefix":"10.1186","volume":"11","author":[{"given":"Xia","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin Gary","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"issue":"1","key":"343_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetmic.2003.12.001","volume":"99","author":"S Oliveira","year":"2004","unstructured":"Oliveira S, Pijoan C. Haemophilus parasuis: new trends on diagnosis, epidemiology and control. Vet Microbiol. 2004;99(1):1\u201312.","journal-title":"Vet Microbiol"},{"issue":"4","key":"343_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1292\/jvms.56.639","volume":"56","author":"H Amano","year":"1994","unstructured":"Amano H, Shibata M, Kajio N, Morozumi T. Pathologic observations of pigs intranasally inoculated with serovar 1, 4 and 5 of Haemophilus parasuis using immunoperoxidase method. J Vet Med Sci. 1994;56(4):639\u201344.","journal-title":"J Vet Med Sci"},{"key":"343_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1746-6148-9-207","volume":"9","author":"R Frandoloso","year":"2013","unstructured":"Frandoloso R, Pivato M, Martinez-Martinez S, Rodriguez-Ferri EF, Kreutz LC, Martin CB. Differences in Haemophilus parasuis adherence to and invasion of AOC-45 porcine aorta endothelial cells. BMC Vet Res. 2013;9:207.","journal-title":"BMC Vet Res"},{"issue":"1\u20134","key":"343_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0378-1135(96)01325-9","volume":"55","author":"GI Solano","year":"1997","unstructured":"Solano GI, Segales J, Collins JE, Molitor TW, Pijoan C. Porcine reproductive and respiratory syndrome virus (PRRSv) interaction with Haemophilus parasuis. Vet Microbiol. 1997;55(1\u20134):247\u201357.","journal-title":"Vet Microbiol"},{"issue":"1\u20134","key":"343_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0378-1135(96)01330-2","volume":"55","author":"JJ Zimmerman","year":"1997","unstructured":"Zimmerman JJ, Yoon KJ, Wills RW, Swenson SL. General overview of PRRSV: a perspective from the United States. Vet Microbiol. 1997;55(1\u20134):187\u201396.","journal-title":"Vet Microbiol"},{"issue":"4","key":"343_CR6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/jcm.30.4.862-865.1992","volume":"30","author":"P Kielstein","year":"1992","unstructured":"Kielstein P, Rapp-Gabrielson VJ. Designation of 15 serovars of Haemophilus parasuis on the basis of immunodiffusion using heat-stable antigen extracts. J Clin Microbiol. 1992;30(4):862\u20135.","journal-title":"J Clin Microbiol"},{"issue":"3\u20134","key":"343_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.vetmic.2005.07.007","volume":"111","author":"X Cai","year":"2005","unstructured":"Cai X, Chen H, Blackall PJ, Yin Z, Wang L, Liu Z, et al. Serological characterization of Haemophilus parasuis isolates from China. Vet Microbiol. 2005;111(3\u20134):231\u20136.","journal-title":"Vet Microbiol"},{"issue":"3\u20134","key":"343_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.vetmic.2004.07.013","volume":"103","author":"O Angen","year":"2004","unstructured":"Angen O, Svensmark B, Mittal KR. Serological characterization of Danish Haemophilus parasuis isolates. Vet Microbiol. 2004;103(3\u20134):255\u20138.","journal-title":"Vet Microbiol"},{"issue":"5","key":"343_CR9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2460\/ajvr.1992.53.05.659","volume":"53","author":"VJ Rapp-Gabrielson","year":"1992","unstructured":"Rapp-Gabrielson VJ, Gabrielson DA. Prevalence of Haemophilus parasuis serovars among isolates from swine. Am J Vet Res. 1992;53(5):659\u201364.","journal-title":"Am J Vet Res"},{"issue":"3","key":"343_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1292\/jvms1939.52.667","volume":"52","author":"T Morikoshi","year":"1990","unstructured":"Morikoshi T, Kobayashi K, Kamino T, Owaki S, Hayashi S, Hirano S. Characterization of Haemophilus parasuis isolated in Japan. Nihon Juigaku Zasshi. 1990;52(3):667\u20139.","journal-title":"Nihon Juigaku Zasshi"},{"issue":"3","key":"343_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0378-1135(99)00007-3","volume":"66","author":"X Rubies","year":"1999","unstructured":"Rubies X, Kielstein P, Costa L, Riera P, Artigas C, Espuna E. Prevalence of Haemophilus parasuis serovars isolated in Spain from 1993 to 1997. Vet Microbiol. 1999;66(3):245\u20138.","journal-title":"Vet Microbiol"},{"issue":"3","key":"343_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1751-0813.2000.tb10586.x","volume":"78","author":"M Rafiee","year":"2000","unstructured":"Rafiee M, Blackall PJ. Establishment, validation and use of the Kielstein-Rapp-Gabrielson serotyping scheme for Haemophilus parasuis. Aust Vet J. 2000;78(3):172\u20134.","journal-title":"Aust Vet J"},{"issue":"1","key":"343_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12223-014-0343-1","volume":"60","author":"Y Yu","year":"2015","unstructured":"Yu Y, Wu G, Zhai Z, Yao H, Lu C, Zhang W. Fifteen novel immunoreactive proteins of Chinese virulent Haemophilus parasuis serotype 5 verified by an immunoproteomic assay. Folia Microbiol. 2015;60(1):81\u20137.","journal-title":"Folia Microbiol"},{"key":"343_CR14","unstructured":"The Europeam Medicines Agency. [http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Maximum_Residue_Limits_-_Report\/2009\/11\/WC500011890.pdf]"},{"issue":"2","key":"343_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2460\/ajvr.75.2.124","volume":"75","author":"JF Rey","year":"2014","unstructured":"Rey JF, Laffont CM, Croubels S, De Backer P, Zemirline C, Bousquet E, et al. Use of Monte Carlo simulation to determine pharmacodynamic cutoffs of amoxicillin to establish a breakpoint for antimicrobial susceptibility testing in pigs. Am J Vet Res. 2014;75(2):124\u201331.","journal-title":"Am J Vet Res"},{"issue":"3","key":"343_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.tvjl.2013.12.015","volume":"199","author":"BX Zhang","year":"2014","unstructured":"Zhang BX, Lu XX, Gu XY, Li XH, Gu MX, Zhang N, et al. Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids. Vet J. 2014;199(3):399\u2013405.","journal-title":"Vet J"},{"key":"343_CR17","volume-title":"Approved Standard VET01-A4","author":"CLSI","year":"2013","unstructured":"CLSI. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. In: Approved Standard VET01-A4. 4th ed. Wayne, PA,USA: CLSI; 2013.","edition":"4"},{"issue":"4","key":"343_CR18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dkq037","volume":"65","author":"S Schwarz","year":"2010","unstructured":"Schwarz S, Silley P, Simjee S, Woodford N, van Duijkeren E, Johnson AP, et al. Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals. J Antimicrob Chemother. 2010;65(4):601\u20134.","journal-title":"J Antimicrob Chemother"},{"issue":"6B","key":"343_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0002-9343(86)90494-8","volume":"80","author":"SH Zinner","year":"1986","unstructured":"Zinner SH, Dudley M, Blaser J. In vitro models for the study of combination antibiotic therapy in neutropenic patients. Am J Med. 1986;80(6B):156\u201360.","journal-title":"Am J Med"},{"issue":"8","key":"343_CR20","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/jac\/dkt112","volume":"68","author":"SS Yang","year":"2013","unstructured":"Yang SS, Sun J, Liao XP, Liu BT, Li LL, Li L, et al. Co-location of the erm(T) gene and blaROB-1 gene on a small plasmid in Haemophilus parasuis of pig origin. J Antimicrob Chemother. 2013;68(8):1930\u20132.","journal-title":"J Antimicrob Chemother"},{"key":"343_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/9781444302639.ch6","volume-title":"Guide to Antimicrobial Use in Animals (Chapter 6)","author":"P Lees","year":"2008","unstructured":"Lees P, Svendsen O, Wiuff C. Strategies to minimize the impact of antimicrobial treatment on the selection of resistant bacteria. In: Guardabassi L, Jensen LB, Kruse H, editors. Guide to Antimicrobial Use in Animals (Chapter 6). Oxford: Wiley-Blackwell; 2008. p. 77\u2013101."},{"issue":"4","key":"343_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0924-8579(02)00027-4","volume":"19","author":"A MacGowan","year":"2002","unstructured":"MacGowan A, Bowker K. Developments in PK\/PD: optimising efficacy and prevention of resistance. A critical review of PK\/PD in in vitro models. Int J Antimicrob Agents. 2002;19(4):291\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"3\u20134","key":"343_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.vetmic.2013.12.021","volume":"171","author":"MG Papich","year":"2014","unstructured":"Papich MG. Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs. Vet Microbiol. 2014;171(3\u20134):480\u20136.","journal-title":"Vet Microbiol"},{"issue":"1","key":"343_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig WA. Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1\u201310. quiz 11-12.","journal-title":"Clin Infect Dis"},{"issue":"1\u20132","key":"343_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0732-8893(95)00053-D","volume":"22","author":"WA Craig","year":"1995","unstructured":"Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis. 1995;22(1\u20132):89\u201396.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"343_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/AAC.45.1.13-22.2001","volume":"45","author":"GL Drusano","year":"2001","unstructured":"Drusano GL, Preston SL, Hardalo C, Hare R, Banfield C, Andes D, et al. Use of preclinical data for selection of a phase II\/III dose for evernimicin and identification of a preclinical MIC breakpoint. Antimicrob Agents Chemother. 2001;45(1):13\u201322.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"343_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1128\/AAC.48.2.369-377.2004","volume":"48","author":"M Mueller","year":"2004","unstructured":"Mueller M, de la Pena A, Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC. Antimicrob Agents Chemother. 2004;48(2):369\u201377.","journal-title":"Antimicrob Agents Chemother"},{"key":"343_CR28","unstructured":"European Committee on Antimicrobial Susceptibility Testing. [http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/Breakpoint_table_v_4.0.pdf]"},{"issue":"2","key":"343_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00003088-198510020-00001","volume":"10","author":"L Balant","year":"1985","unstructured":"Balant L, Dayer P, Auckenthaler R. Clinical pharmacokinetics of the third generation cephalosporins. Clin Pharmacokinet. 1985;10(2):101\u201343.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"343_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.diagmicrobio.2006.06.019","volume":"56","author":"PF Smith","year":"2006","unstructured":"Smith PF, Tsuji B, Booker BM, Forrest A, Bajic S, Kelchlin P, et al. Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model. Diagn Microbiol Infect Dis. 2006;56(4):379\u201386.","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-015-0343-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0343-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-015-0343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T05:05:49Z","timestamp":1717736749000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-015-0343-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1186\/s12917-015-0343-7","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]},"assertion":[{"value":"15 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"33"}}